Serial Number:
86826912
Mark:
BENDEKA (BENDAMUSTINE HCI) INJECTION
Status:
Section 8 and 15-accepted and acknowledged
Status Date:
02-17-2023
Filing Date:
Registration Number:
5014704
Registration Date:
08-02-2016
Providing an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma
Mark Description:
The mark consists of the word "BENDEKA" in capital orange letters with the words "bendamustine HCI" in lower case gray letters directly underneath in parenthesis and the word "injection" in lower case gray letters directly underneath. There is a tilted triangle shape of gray, lime green and orange ribbons directly to the left of the word "BENDEKA".
Class:
Medical services
Type of Mark:
Servicemark
Published for Opposition Date:
03-08-2016
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
N/A
Business Name:
TEVA PHARMACEUTICALS USA, INC.
Correspondent Name:
